Axon Enterprise, Inc $AXON Shares Bought by PensionDanmark Pensionsforsikringsaktieselskab

PensionDanmark Pensionsforsikringsaktieselskab grew its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 44.2% during the 2nd quarter, Holdings Channel reports. The fund owned 11,160 shares of the biotechnology company’s stock after acquiring an additional 3,420 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Axon Enterprise were worth $6,256,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the stock. Creative Financial Designs Inc. ADV purchased a new stake in Axon Enterprise during the 4th quarter worth about $28,000. Sound Income Strategies LLC raised its stake in Axon Enterprise by 550.0% in the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after purchasing an additional 44 shares during the last quarter. Camelot Portfolios LLC purchased a new position in Axon Enterprise in the 4th quarter valued at about $30,000. AlphaCentric Advisors LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter worth about $34,000. Finally, Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the 2nd quarter worth about $37,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on AXON. Needham & Company LLC reissued a “buy” rating on shares of Axon Enterprise in a research report on Thursday. Citizens Jmp restated a “market outperform” rating and set a $700.00 target price on shares of Axon Enterprise in a research report on Thursday, June 25th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday. Barclays boosted their price target on Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a report on Thursday. Finally, TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, July 22nd. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $730.92.

Axon Enterprise Trading Up 9.3%

Shares of AXON stock opened at $571.01 on Friday. The firm has a market cap of $46.02 billion, a P/E ratio of 236.93, a PEG ratio of 11.65 and a beta of 1.39. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $878.62. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.93. The firm’s 50-day simple moving average is $513.80 and its 200-day simple moving average is $474.59.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. During the same period in the previous year, the firm earned $2.12 earnings per share. Axon Enterprise’s revenue was up 35.3% compared to the same quarter last year. As a group, equities analysts forecast that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Strong Q2 growth and higher outlook: Axon reported second-quarter revenue of approximately $904 million, up 35% year over year and above analyst expectations. The company raised its 2026 revenue-growth forecast to 32%–34%, citing record bookings, international expansion and demand for its connected devices and software. Axon Beat Estimates and Raised Guidance, Shares Dropped
• Positive Sentiment: AI and Dedrone momentum: AI Era revenue, including Draft One automated police-report software, grew nearly 700% from a year earlier. Dedrone counter-drone revenue exceeded $100 million, supported by deployments at all 11 World Cup sites, strengthening Axon’s long-term growth narrative. Axon Stock Falls After AI, Drone Wins Fuel Q2 Earnings Beat
• Positive Sentiment: Analyst and retail support: UBS raised its price target to $600 while maintaining a Neutral rating, and retail traders showed interest in buying the post-earnings pullback. William Blair also reiterated a Buy rating, highlighting recurring-revenue growth, counter-drone demand and Axon’s expanding AI platform. UBS Raises Axon Price Target
• Neutral Sentiment: Valuation remains elevated: Axon’s rapid share-price recovery has increased scrutiny of its valuation. Some analysis considers the stock expensive on discounted cash flow and only fairly valued on sales multiples, potentially limiting further gains unless growth remains strong. Axon Stock Could Be Overvalued
• Negative Sentiment: Margins and cash flow pressured the initial reaction: Software gross margin declined to 71.3% from 75.6%, while a greater mix of professional services, memory costs and investments in new products reduced profitability. Free cash flow also turned negative, and quarterly EPS was reported as slightly below some consensus estimates, prompting an initial post-earnings selloff. Axon Posts Lower Quarterly Gross Margin

Insider Activity at Axon Enterprise

In other news, CRO Cameron Brooks sold 1,242 shares of the company’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $621,000.00. Following the completion of the sale, the executive directly owned 49,710 shares in the company, valued at $24,855,000. This represents a 2.44% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 13,000 shares of the stock in a transaction on Friday, June 5th. The stock was sold at an average price of $488.45, for a total value of $6,349,850.00. Following the completion of the transaction, the president directly owned 169,125 shares in the company, valued at $82,609,106.25. This trade represents a 7.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 58,989 shares of company stock valued at $30,527,983 over the last 90 days. 4.20% of the stock is currently owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.